Adrenomed AG
PrivateLast Round
Series E
Nov 30, 2020
Total Funding Raised
$53.77M
Company Overview
Adrenomed AG operates in Healthcare & Life Sciences and is based in Hennigsdorf. Its latest recorded funding round was a Series E round in November 2020.
Adrenomed AG is a biopharmaceutical company that develops a first-in-class antibody to rescue vascular integrity in critically ill patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adrenomed AG Comparables
Compare Adrenomed AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inotrem | 88% | |
| 4TEEN4 Pharmaceuticals GmbH | 87% | |
| Matisse Pharmaceuticals | 83% |
For institutional investors. Book with your work email.
Adrenomed AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Nov 30, 2020 | ||||
| Series D | Nov 26, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Adrenomed AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitionsbank des Landes Brandenburg | Series D |
| HBM Healthcare Investments | Debt, Series E, Series D |
| Wellington Partners | Debt, Series E, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Monthly visitors grew 81% MoM.
- May 4, 2025
Monthly visitors grew 75% MoM.
For institutional investors. Book with your work email.
Adrenomed AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Adrenomed AG's valuation, stock price, and market status.
Is Adrenomed AG a public or private company?
Adrenomed AG is a private company.
What is the current stock price of Adrenomed AG?
Adrenomed AG is a private company, so its shares have no public market price. Caplight tracks Adrenomed AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adrenomed AG worth (valuation)?
Valuation information for Adrenomed AG is not publicly available.
Can I buy Adrenomed AG stock?
Adrenomed AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adrenomed AG's last funding round?
Adrenomed AG's most recent funding round was Series E on November 30, 2020.
Who are the main investors in Adrenomed AG?
Key investors in Adrenomed AG include HBM Healthcare Investments, Wellington Partners.
Will Adrenomed AG IPO soon?
No public IPO plans have been announced for Adrenomed AG.
How can I track Adrenomed AG secondary market activity?
Caplight tracks bids, offers, and trades in Adrenomed AG's shares on secondary markets.